Stimulation of natural killer T cells by glycolipids
- PMID: 24352021
- PMCID: PMC4018217
- DOI: 10.3390/molecules181215662
Stimulation of natural killer T cells by glycolipids
Abstract
Natural killer T (NKT) cells are a subset of T cells that recognize glycolipid antigens presented by the CD1d protein. The initial discovery of immunostimulatory glycolipids from a marine sponge and the T cells that respond to the compounds has led to extensive research by chemists and immunologists to understand how glycolipids are recognized, possible responses by NKT cells, and the structural features of glycolipids necessary for stimulatory activity. The presence of this cell type in humans and most mammals suggests that it plays critical roles in antigen recognition and the interface between innate and adaptive immunity. Both endogenous and exogenous natural antigens for NKT cells have been identified, and it is likely that glycolipid antigens remain to be discovered. Multiple series of structurally varied glycolipids have been synthesized and tested for stimulatory activity. The structural features of glycolipids necessary for NKT cell stimulation are moderately well understood, and designed compounds have proven to be much more potent antigens than their natural counterparts. Nevertheless, control over NKT cell responses by designed glycolipids has not been optimized, and further research will be required to fully reveal the therapeutic potential of this cell type.
Figures








Similar articles
-
Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.Ann N Y Acad Sci. 2012 Apr;1253(1):68-79. doi: 10.1111/j.1749-6632.2011.06435.x. Epub 2012 Feb 21. Ann N Y Acad Sci. 2012. PMID: 22352829 Free PMC article. Review.
-
Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.Semin Immunol. 2010 Apr;22(2):68-78. doi: 10.1016/j.smim.2009.10.003. Epub 2009 Nov 27. Semin Immunol. 2010. PMID: 19945296 Free PMC article. Review.
-
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria.Nat Immunol. 2011 Sep 4;12(10):966-74. doi: 10.1038/ni.2096. Nat Immunol. 2011. PMID: 21892173 Free PMC article.
-
Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10984-9. doi: 10.1073/pnas.1000576107. Epub 2010 Jun 1. Proc Natl Acad Sci U S A. 2010. PMID: 20534460 Free PMC article.
-
Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.J Vis Exp. 2007;(10):635. doi: 10.3791/635. Epub 2007 Dec 31. J Vis Exp. 2007. PMID: 18989407 Free PMC article.
Cited by
-
Development of α-GalCer Analogues with an α-Fluorocarbonyl Moiety as Th2-Selective Ligands of CD1d.ACS Med Chem Lett. 2019 Apr 24;10(5):773-779. doi: 10.1021/acsmedchemlett.9b00026. eCollection 2019 May 9. ACS Med Chem Lett. 2019. PMID: 31097998 Free PMC article.
-
Psychosine variants as antigens for natural killer T cells.Chem Sci. 2017 Mar 1;8(3):2204-2208. doi: 10.1039/c6sc04218j. Epub 2016 Dec 9. Chem Sci. 2017. PMID: 28507675 Free PMC article.
-
Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.J Immunol. 2015 Sep 15;195(6):2710-21. doi: 10.4049/jimmunol.1403017. Epub 2015 Aug 7. J Immunol. 2015. PMID: 26254338 Free PMC article.
-
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Oncotarget. 2016 Apr 26;7(17):23128-40. doi: 10.18632/oncotarget.7440. Oncotarget. 2016. PMID: 26895468 Free PMC article. Review.
-
Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells.Front Immunol. 2017 Jul 21;8:848. doi: 10.3389/fimmu.2017.00848. eCollection 2017. Front Immunol. 2017. PMID: 28785267 Free PMC article.
References
-
- Pellicci D.G., Patel O., Kjer-Nielsen L., Pang S.S., Sullivan L.C., Kyparissoudis K., Brooks A.G., Reid H.H., Gras S., Lucet I.S.;et al. Differential recognition of CD1d-alpha-galactosyl ceramide by the v beta 8.2 and v beta 7 semi-invariant NKT T cell receptors. Immunity. 2009;31:47–59. doi: 10.1016/j.immuni.2009.04.018. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources